May 28, 2025

Australian veterans gain subsidized access to SyqeAir Inhaler

Australian veterans now have subsidised access to the SyqeAir Inhaler, following TGA approval — a major step in expanding safe, metered medical cannabis treatment through government-supported programs.

The Pharmacokinetics, Efficacy, Safety, and Ease of Use of the SyqeAir Metered-Dose Cannabis Inhaler for Chronic Neuropathic Pain: A Phase 1a Study

12/12/2024

Syqe®’s first study (2014) examined whether metered and low doses of Δ9-THC allow for dose-dependent pain reduction of chronic neuropathic pain without significant adverse events. Listen to the podcast.

SyqeAir Recognized as a Leading Israeli Medical Innovation

19/01/2025

SyqeAir is making waves! We’re proud to share that Israel21c has recognized the SyqeAir Inhaler as one of the 12 most amazing Israeli medical advances.

Study Finds Medical Cannabis Reduces Cancer Patients’ Pain And Need For Opiates

25/05/2022

Researchers in Israel found that the use of medical cannabis reduced cancer patients’ pain and use of painkillers in a recently published study.

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.

Day: May 28, 2025

Australian veterans gain subsidized access to SyqeAir Inhaler

Related Posts

The Pharmacokinetics, Efficacy, Safety, and Ease of Use of the SyqeAir Metered-Dose Cannabis Inhaler for Chronic Neuropathic Pain: A Phase 1a Study

SyqeAir Recognized as a Leading Israeli Medical Innovation

Study Finds Medical Cannabis Reduces Cancer Patients’ Pain And Need For Opiates